This inventor holds 2 USPTO granted patents. Top assignees: Eliza nor Biopharmaceuticals, Inc., Other. Active years: 1999-2001.
Company Filing History:
1 out of 1 
1 out of 834,453 Years Active: 1999-2001
Title: The Innovative Contributions of Pal Herczegh
Introduction
Pal Herczegh is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Herczegh's work focuses on therapeutic derivatives that address various medical challenges.
Latest Patents
Herczegh's latest patents include "Therapeutic derivatives of diphosphonates" and "Therapeutic derivations of diphosphonates." The first patent describes compounds that are prepared by reacting a 2,2-bis-(disubstituted-phosphoryl)-ethylsulfanyl-acetic acid compound with a pharmaceutically active chemical entity. This invention aims to treat underlying disease states or to interact with non-pharmaceutical entities such as pesticides, insecticides, fungicides, or poisons for vermin. The second patent introduces novel chemotherapeutic agents that are effective in treating infectious diseases, including periodontal disease and certain urinary tract infections. These agents are obtained by combining a diphosphonate compound with a therapeutic agent effective against these diseases.
Career Highlights
Throughout his career, Pal Herczegh has worked with various companies, including Eliza Nor Biopharmaceuticals, Inc. His experience in the biopharmaceutical industry has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Herczegh has collaborated with notable individuals in his field, including John F. Hartmann and Ferenc J. Sztaricskai. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Pal Herczegh's contributions to the field of biopharmaceuticals through his innovative patents demonstrate his commitment to addressing significant health challenges. His work continues to impact the industry positively, showcasing the importance of innovation in medicine.